Last reviewed · How we verify
Citrullinemia — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Buphenyl | Buphenyl | Amgen | Aldose reductase, Histone deacetylase 1, Histone deacetylase 2 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Amgen · 1 drug in Citrullinemia
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Citrullinemia:
- Citrullinemia treatment updates — RSS
- Citrullinemia treatment updates — Atom
- Citrullinemia treatment updates — JSON
Cite this brief
Drug Landscape (2026). Citrullinemia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/citrullinemia. Accessed 2026-06-10.
Related
- Citrullinemia full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing